Announcement

Collapse
No announcement yet.

Eur J Health Econ . Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC 4 E trial in 15 European countries

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
Working...
X